MET and cancer: The activation of genes such as NR4A3, MET, ZEB1, CSF1, CSF2, CSF3, which can be involved in transcriptional dysregulation in cancer or hematopoietic cell lineage signaling pathways, can also be involved in cell differentiation [25–27].